Fig. 2From: Dramatic response to alectinib in a patient of ALK-rearranged lung cancer with poor performance statusBronchoscopy showing tumor obstruction in a visible range from the truncus intermedius to right lower lobe bronchus (a). Bronchoscopy taken 2 weeks after the initiation of alectinib showing dramatic shrinkage of right lower bronchus (b)Back to article page